Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | LCK | P06239 | 1/20 | 0.59 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.59 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6237406 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2709599 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL22842 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL337352 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL525700 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2933185 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL525619 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL4757199 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL525377 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL525702 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113557259-B | Biosynthesis of gamma-and delta-lactones using cytochrome P450 enzymes with subterminal hydroxylase activity | 科纳根公司 | 2024-03-08 | — | — | CN | claimed |
| EP-4139387-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| CN-115461396-A | Additive composition and use thereof, condensation polymer composition, moulding compound and moulded part produced therefrom and use thereof | 弗劳恩霍夫应用研究促进协会 | 2022-12-09 | — | — | CN | claimed |
| WO-2021213939-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-10-28 | — | — | WO | claimed |
| CN-113557259-A | Biosynthetic production of gamma-lactones and delta-lactones using cytochrome P450 enzymes with sub-terminal hydroxylase activity | 科纳根公司 | 2021-10-26 | — | — | CN | claimed |
| US-11112717-B2 | Electrostatic ink compositions and scratch-off structures | HP INDIGO B.V. (NL) | 2021-09-07 | — | — | US | claimed |
| US-20050287101-A1 | Cosmetic composition comprising at least one semi-crystalline polymer, and at least one ester of dimer diol and of acid | STEEL FUNDING, LLC | 2005-12-29 | — | — | US | claimed |
| US-20050287103-A1 | Cosmetic composition comprising at least one ester and at least one film-forming polymer | L'OREAL S.A. (FR) | 2005-12-29 | — | — | US | claimed |
| US-20040175338-A1 | Cosmetic composition containing an ester and a pasty compound | L'OREAL (FR) | 2004-09-09 | — | — | US | claimed |
| US-6740731-B2 | COMPRISING A HYDROXYCARBOXYLIC ACID-CONTAINING POLYMER WHERE THE POLYMER BIODEGRADES HYDROLYTICALLY DURING STORAGE, USE AND DISPOSAL STAGES IN A CONTROLLED MANNER,THE RATE BEING ACCELERATED DURING DISPOSAL; MICROBIOCIDES | CARGILL DOW POLYMERS LLC | 2004-05-25 | — | — | US | claimed |
| US-20020123546-A1 | Degradation control of environmentally degradable disposable materials | ECOPOL, LLC | 2002-09-05 | — | — | US | claimed |
| EP-1044278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 2000-10-18 | — | — | EP | claimed |
| US-6008169-A | Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof | IDEMITSU KOSAN CO., LTD. (JP) | 1999-12-28 | — | — | US | claimed |
| WO-1999035278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 1999-07-15 | — | — | WO | claimed |
| EP-0662107-A4 | DEGRADATION CONTROL OF ENVIRONMENTALLY DEGRADABLE DISPOSABLE MATERIALS. | BIOPAK TECHNOLOGY LTD (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0662107-A1 | DEGRADATION CONTROL OF ENVIRONMENTALLY DEGRADABLE DISPOSABLE MATERIALS | BioPak Technology, Ltd. (US) | 1995-07-12 | — | — | EP | claimed |
| WO-1994006866-A1 | DEGRADATION CONTROL OF ENVIRONMENTALLY DEGRADABLE DISPOSABLE MATERIALS | BIOPAK TECHNOLOGY, LTD. (US) | 1994-03-31 | — | — | WO | claimed |
| EP-0000560-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALPHA-HYDROXYCARBOXYLIC ACIDS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-02-03 | — | — | EP | claimed |
| US-4204044-A | SELECTIVE ASYMMETRIC, ENZYMATIC DEHYDROGENATIKN USING STREPTOMYCES, PSEUDOMONAS, BACILLUS OR CORYNEFORM MICROORGANISMS | HOFFMANN-LA ROCHE INC. (US) | 1980-05-20 | — | — | US | claimed |
| EP-0000560-A1 | Process for the preparation of optically active alpha-hydroxycarboxylic acids | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-02-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050287103-A1 | Cosmetic composition comprising at least one ester and at least one film-forming polymer | DAGLA, CUTA, DSG1 | GPR84 2270/4885FFAR1 211/4885MAPT 2776/4885 |
| US-20050287101-A1 | Cosmetic composition comprising at least one semi-crystalline polymer, and at least one ester of dimer diol and of acid | CUTA, C9, DHCR24 | GPR84 1419/4885FFAR1 277/4885MAPT 1143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.